Page last updated: 2024-12-10

3,7,11,15-tetramethyl-1,2,3-hexadecanetriol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,7,11,15-tetramethyl-1,2,3-hexadecanetriol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phytantriol : A triol that consists of 3,7,11,15-tetramethylhexadecane bearing three hydroxy substituents at positions 1, 2 and 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3018525
CHEBI ID47770
SCHEMBL ID49962
MeSH IDM0496243

Synonyms (28)

Synonym
phytantriol
3,7,11,15-tetramethylhexadecane-1,2,3-triol
74563-64-7
1,2,3-trihydroxy-3,7,11,15-tetramethylhexadecane
P1674
einecs 277-923-2
8lvi07a72w ,
unii-8lvi07a72w
1,2,3-hexadecanetriol, 3,7,11,15-tetramethyl-
3,7,11,15,-tetramethyl-1,2,3-hexadecanetriol
3,7,11,15-tetramethyl-1,2,3-hexadecanetriol
CHEBI:47770
1,2,3-hexadecanetriol,3,7,11,15-tetramethyl-
oristar ptt
phytantriol [inci]
phytantriol [mi]
tetramethyl trihydroxyhexadecane
SCHEMBL49962
AKOS028110025
AS-66189
3,7,11,15-tetramethyl-1,2,3-hexadecane-triol
DTXSID10868315
CS-0205401
CGIHFIDULQUVJG-UHFFFAOYSA-N
mfcd00129085
Q27120789
AMY13855
T72899

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Oral LD50 values in mice and rats were reported to be > 5000 mg/kg."( Final report on the safety assessment of phytantriol.
, 2007
)
0.34

Bioavailability

ExcerptReferenceRelevance
" The results showed a trend by which the rate of absorption of (14)C-glucose followed that observed in the corresponding in vitro release studies, providing the first indication that the nanostructure of these materials may provide the ability to tailor the absorption kinetics of hydrophilic drugs in vivo, and hence form the basis of a new drug delivery system."( Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
Boyd, BJ; Hanley, T; Lee, KW; Nguyen, TH, 2009
)
0.35
" Oral bioavailability studies were conducted in rats, and disposition of lipid and drug in segments of the gastrointestinal tract was determined over time."( Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Boyd, BJ; Hanley, T; Larson, I; Nguyen, TH; Porter, CJ, 2010
)
0.36
"The oral bioavailability of cinnarizine using the PHY formulation was 41%, compared to 19% for the GMO formulation and 6% for an aqueous suspension."( Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Boyd, BJ; Hanley, T; Larson, I; Nguyen, TH; Porter, CJ, 2010
)
0.36
"05) in oral bioavailability (F%=21%) compared to a CZ suspension (9%) and oleic acid emulsion (12%)."( Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
Boyd, BJ; Hanley, T; Nguyen, TH; Porter, CJ, 2011
)
0.37
" Interestingly, it was found that PHY 30 % w/w in GMO provided the highest bioavailability for cinnarizine (CZ) amongst the other combinations, including GMO alone."( Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
Boyd, BJ; Graham, B; Nguyen, TH; Nowell, CJ; Pham, AC, 2015
)
0.42
" This study presents the development of self-assembled cubic lipid-based crystalline nanoparticles to enhance inner ear bioavailability of bioactive NGF via a round window membrane route."( Enhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochlea.
Bu, M; Liu, H; Sun, Y; Tang, J; Wang, X; Wei, Y; Wu, L, 2015
)
0.42
"28-fold increase in inner ear bioavailability was observed after administration of phytantriol lipid-based crystalline nanoparticles as compared to free drug, contributing to an enhanced drug permeability of the round window membrane."( Enhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochlea.
Bu, M; Liu, H; Sun, Y; Tang, J; Wang, X; Wei, Y; Wu, L, 2015
)
0.42
"To improve the solubility and bioavailability of oridonin (ORI), glycerol monooleate lipid (GMO)- or phytantriol (PYT)-Poloxamer 407-propylene glycol-water systems were firstly used to develop cubosomes containing ORI for oral delivery."( Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
Gu, Y; Han, K; Hu, C; Huang, J; Huang, Y; Li, G; Mei, L; Pan, X; Peng, T; Shi, X; Wu, C, 2017
)
0.46
"Present investigation deals with formulation and evaluation of tamoxifen (TMX)-loaded liquid crystalline nanoparticles (TMX-LCNPs) for improving oral bioavailability and safety of the existing treatment."( Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles.
Heeralal, B; Jain, S; Kushwah, V; Swami, R; Swarnakar, NK, 2018
)
0.48
"Implication of different dietary specific lipids such as phytantriol (PT) and glyceryl monooleate (GMO) on enhancing the oral bioavailability of amphotericin B (AmB) was examined."( Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement.
Jain, S; Katiyar, SS; Kushwah, V; Swami, R; Swarnakar, NK; Yadav, P, 2018
)
0.48
"The purpose of this paper was to investigate the potential of liquid crystalline (LC) gels for ophthalmic delivery, so as to enhance the bioavailability of pilocarpine nitrate (PN)."( A Novel Phytantriol-Based Lyotropic Liquid Crystalline Gel for Efficient Ophthalmic Delivery of Pilocarpine Nitrate.
Cao, J; Chu, X; Gui, S; Huang, J; Li, Z; Liu, L; Tian, C; Wang, X; Xia, M; Zhang, Y, 2019
)
0.51
"The aim of this study was to investigate the release behaviors of sinomenine hydrochloride loaded via in situ hexagonal liquid crystal (ISH), and its potential to improve the local bioavailability in knee joints of sinomenine hydrochloride (SMH) after intra-articular administration."( In situ hexagonal liquid crystal for intra-articular delivery of sinomenine hydrochloride.
Chen, Y; Gui, S; Liang, X; Maharjan, A; Regmi, B; Wu, L; Zhang, J, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (3 Product(s))

Product Categories

Product CategoryProducts
Baby & Kids Products1
Beauty & Personal Care2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Fairy Tales Curly-Q Hydrating Conditioner -- 8 fl ozFairy TalesBaby & Kids Productscaprylyl glycol, phytantriol, citric acid, benzyl alcohol, cetearyl alcohol, citric acid, cyclopentasiloxane, dehydroacetic acid, panthenol, phenoxyethanol, sorbic acid2024-11-29 10:47:42
Jason Intense Moisture Conditioner Aloe Vera + Prickly Pear -- 16 fl ozJasonBeauty & Personal Careisopropyl alcohol, phytantriol, citric acid, ascorbyl palmitate, linolenic acid, terpineol, benzyl alcohol, betaine, cetearyl alcohol, cetyl alcohol, citric acid, panthenol, triethyl citrate, glycerin, linoleic acid, phenoxyethanol, phenethyl alcohol, stearyl alcohol2024-11-29 10:47:42
Miracle Anti-Aging™ Shampoo -- 6 fl ozMiracleBeauty & Personal Carephytantriol, citric acid, methylchloroisothiazolinone, ascorbyl palmitate, vitamin E acetate, citric acid, cocamidopropyl betaine, panthenol, pro-vitamin B5, glycerin, linoleic acid, menthol, retinyl palmitate2024-11-29 10:47:42

Drug Classes (1)

ClassDescription
triolA chemical compound containing three hydroxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (109)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (13.76)29.6817
2010's77 (70.64)24.3611
2020's17 (15.60)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.31 (24.57)
Research Supply Index4.71 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.73%)6.00%
Case Studies1 (0.91%)4.05%
Observational0 (0.00%)0.25%
Other106 (96.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]